IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on November 3, 2026

Nov. 3, 2026

Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation

Indeterminate GlobeNewswire

Nov. 3, 2026

Bond Announces Strategic Financial Realignment, Converting Approximately $15 Million of Debt and Preferred Stock into Equity

Indeterminate GlobeNewswire

Nov. 3, 2026

Aeries Technology to Report Second-Quarter Fiscal 2027 Results on November 5, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Conavi Medical Presents Data Demonstrating Feasibility of Saline-Based Hybrid IVUS–OCT Imaging with OCTIV™ at TCT 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Intermap Appoints Terry Ryan to Board of Directors

Indeterminate GlobeNewswire

Nov. 3, 2026

Creative Realities, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call Information

Indeterminate GlobeNewswire

Nov. 3, 2026

BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Ascentage Pharma to Participate in Two Upcoming Investor Conferences in London

Indeterminate GlobeNewswire

Nov. 3, 2026

Palvella Therapeutics to Participate in the Stifel 2026 Healthcare Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Decoy Therapeutics Provides Third Quarter 2026 Business Update

Indeterminate GlobeNewswire

Nov. 3, 2026

Kailera Therapeutics to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Nexera Technologies: Subsidiary Fort Technology Announces Receipt of Approval for a Voluntary Delisting of its Common Shares From the TSX Venture Exchange

Indeterminate GlobeNewswire

Nov. 3, 2026

Renee Mustered Announces a New Milestone in Vilomah’s Development as a Grief-Support Platform

Indeterminate GlobeNewswire

Nov. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 3, 2026

Viirtue Moves Into New Downtown St. Petersburg Office at 360 Central Avenue

Indeterminate EIN Presswire

Nov. 3, 2026

Louis Garoz-Ferguson's Kadenwood Group Advised Doosan GridTech on a Carve-Out Sale

Indeterminate EIN Presswire

Nov. 3, 2026

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

Indeterminate GlobeNewswire

Nov. 3, 2026

Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities

Indeterminate GlobeNewswire

Nov. 3, 2026

Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion

Indeterminate GlobeNewswire

Nov. 3, 2026

Cardiff Oncology to Participate in the UBS Global Biopharma Conference

Indeterminate GlobeNewswire